Fidelity Investments’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Buy |
3,558,655
+1,342,221
| +61% | +$6.76M | ﹤0.01% | 1727 |
|
|
2025
Q1 | $14.4M | Buy |
2,216,434
+2,209,318
| +31,047% | +$14.3M | ﹤0.01% | 1791 |
|
|
2024
Q4 | $52.2K | Buy |
7,116
+5,882
| +477% | +$43.2K | ﹤0.01% | 3831 |
|
|
2024
Q3 | $9.24K | Sell |
1,234
-6,799
| -85% | -$50.9K | ﹤0.01% | 4443 |
|
|
2024
Q2 | $71.5K | Buy |
8,033
+1,327
| +20% | +$11.8K | ﹤0.01% | 3442 |
|
|
2024
Q1 | $67.9K | Buy |
6,706
+333
| +5% | +$3.37K | ﹤0.01% | 3442 |
|
|
2023
Q4 | $64.1K | Sell |
6,373
-147,289
| -96% | -$1.48M | ﹤0.01% | 3407 |
|
|
2023
Q3 | $1.44M | Sell |
153,662
-106,134
| -41% | -$994K | ﹤0.01% | 2374 |
|
|
2023
Q2 | $6.37M | Buy |
259,796
+127,018
| +96% | +$3.12M | ﹤0.01% | 1994 |
|
|
2023
Q1 | $3.09M | Buy |
132,778
+62,328
| +88% | +$1.45M | ﹤0.01% | 2246 |
|
|
2022
Q4 | $1.78M | Buy |
70,450
+23,010
| +49% | +$582K | ﹤0.01% | 2410 |
|
|
2022
Q3 | $914K | Buy |
47,440
+13,245
| +39% | +$255K | ﹤0.01% | 2631 |
|
|
2022
Q2 | $870K | Buy |
34,195
+2,063
| +6% | +$52.5K | ﹤0.01% | 2715 |
|
|
2022
Q1 | $826K | Sell |
32,132
-251,514
| -89% | -$6.47M | ﹤0.01% | 2829 |
|
|
2021
Q4 | $11.9M | Buy |
+283,646
| New | +$11.9M | ﹤0.01% | 2044 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 5090 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4929 |
|
|
2021
Q1 | – | Sell |
-6
| Closed | – | – | 4573 |
|
|
2020
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4314 |
|